 |
|
A Randomized Trial of Vitamin E Supplementation and Cognitive Function in Women
Jae Hee Kang, ScD;
Nancy Cook, ScD;
JoAnn Manson, MD, DrPH;
Julie E. Buring, ScD;
Francine Grodstein, ScD
Arch Intern Med. 2006;166:2462-2468.
Background Oxidative stress may play a key role in the development of cognitive impairment. Long-term supplementation with vitamin E, a strong antioxidant, may provide cognitive benefits.
Methods The Women's Health Study is a randomized, double-blind, placebo-controlled trial of vitamin E supplementation (600 IU [ -tocopherol acetate], on alternate days) begun between 1992 and 1995 among 39 876 healthy US women. From 1998, 6377 women 65 years or older participated in a cognitive substudy. Three cognitive assessments of general cognition, verbal memory, and category fluency were administered by telephone at 2-year intervals. The primary outcome was a global composite score averaging performance on all tests. Repeated measures analyses were conducted to examine mean performance and mean differences in cognitive change, and logistic regression was used to estimate relative risks of substantial decline.
Results There were no differences in global score between the vitamin E and placebo groups at the first assessment (5.6 years after randomization: mean difference, –0.01; 95% confidence interval [CI], –0.04 to 0.03) or at the last assessment (9.6 years of treatment: mean difference, 0.00; 95% CI, –0.04 to 0.04). Mean cognitive change over time was also similar in the vitamin E group compared with the placebo group for the global score (mean difference in change, 0.02; 95% CI, –0.01 to 0.05; P = .16). The relative risk of substantial decline in the global score in the vitamin E group compared with the placebo group was 0.92 (95% CI, 0.77 to 1.10).
Conclusion Long-term use of vitamin E supplements did not provide cognitive benefits among generally healthy older women.
Author Affiliations: Channing Laboratory (Drs Kang, Manson, and Grodstein) and Division of Preventive Medicine (Drs Cook, Manson, and Buring), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Department of Epidemiology, Harvard School of Public Health (Drs Manson, Buring, and Grodstein), Boston, Mass.
RELATED ARTICLE
Preventing Cognitive Decline in Usual Aging
Mark A. Espeland and Victor W. Henderson
Arch Intern Med. 2006;166(22):2433-2434.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort
Ravaglia et al.
Am. J. Clin. Nutr. 2008;87:1306-1313.
ABSTRACT
| FULL TEXT
Antioxidants and Prevention of Cognitive Decline: Does Duration of Use Matter?
Yaffe
Arch Intern Med 2007;167:2167-2168.
FULL TEXT
A Randomized Trial of Beta Carotene Supplementation and Cognitive Function in Men: The Physicians' Health Study II
Grodstein et al.
Arch Intern Med 2007;167:2184-2190.
ABSTRACT
| FULL TEXT
Combining an Antioxidant-Fortified Diet with Behavioral Enrichment Leads to Cognitive Improvement and Reduced Brain Pathology in Aging Canines: Strategies for Healthy Aging
HEAD
Ann. N. Y. Acad. Sci. 2007;1114:398-406.
ABSTRACT
| FULL TEXT
Low dose aspirin and cognitive function in the women's health study cognitive cohort
Kang et al.
BMJ 2007;334:987-987.
ABSTRACT
| FULL TEXT
Vitamin E and Cognitive Function in Women
JWatch Neurology 2007;2007:3-3.
FULL TEXT
Childhood intelligence and being a vegetarian
Richards
BMJ 2007;334:216-217.
FULL TEXT
Vitamin E Supplementation Fails to Prevent Cognitive Decline
JWatch General 2007;2007:5-5.
FULL TEXT
Preventing Cognitive Decline in Usual Aging
Espeland and Henderson
Arch Intern Med 2006;166:2433-2434.
FULL TEXT
|
